SYROS PHARMACEUTICALS, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2018-02-09: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-01-08; Total offering amount $11,380,018.
- 2018-01-17: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-01-08; Total offering amount $9,999,995.
- 2014-10-24: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2014-10-09; Total offering amount $53,149,996.
- 2013-04-22: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2013-04-10; Total offering amount $12,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2018-02-09 D/A | Rule 506(b) | Equity | 2018-01-08 | $11,380,018 | $11,380,018 | $0 | 1 |
| 2018-01-17 | Rule 506(b) | Equity | 2018-01-08 | $9,999,995 | $9,999,995 | $0 | 1 |
| 2014-10-24 | Rule 506(b) | Equity | 2014-10-09 | $53,149,996 | $53,149,996 | $0 | 16 |
| 2013-04-22 | Rule 506 | Equity | 2013-04-10 | $12,000,000 | $10,000,000 | $2,000,000 | 3 |
| 2012-08-22 | Rule 506 | Equity | 2012-08-08 | $1,250,000 | $1,250,000 | $0 | 4 |